Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Other Non-Current Assets (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Other Non-Current Assets for 16 consecutive years, with $1000.0 as the latest value for Q3 2025.

  • Quarterly Other Non-Current Assets fell 99.03% to $1000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $1000.0 through Sep 2025, down 99.03% year-over-year, with the annual reading at $103000.0 for FY2024, 26.95% down from the prior year.
  • Other Non-Current Assets for Q3 2025 was $1000.0 at Xtant Medical Holdings, down from $15000.0 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $322000.0 in Q1 2021, with the low at $1000.0 in Q1 2025.
  • Average Other Non-Current Assets over 5 years is $170157.9, with a median of $185000.0 recorded in 2023.
  • The sharpest move saw Other Non-Current Assets dropped 8.68% in 2022, then crashed 99.24% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $287000.0 in 2021, then tumbled by 31.36% to $197000.0 in 2022, then decreased by 28.43% to $141000.0 in 2023, then fell by 26.95% to $103000.0 in 2024, then crashed by 99.03% to $1000.0 in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $1000.0, $15000.0, and $1000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.